GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹146 Cr | ₹137 Cr | - | - | - |
What is the latest Long Term Provisions ratio of GLAND PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹146 Cr |
| Mar2024 | ₹137 Cr |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Long Term Provisions of GLAND PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹146 Cr | 6.40 | |
| Mar2024 | ₹137 Cr | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Long Term Provisions of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹40,058.7 Cr | -2.3% | 4.9% | 18.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -2.3% |
4.9% |
18.9% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses